CSS
DNA icon

Cubist Systematic Strategies’s Ginkgo Bioworks DNA Stock Holding History

Cubist Systematic Strategies’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,743
Closed -$290K – 3116
2025
Q2 		$290K Sell
25,743
-413,516
-94% -$3.2M ﹤0.01% 2473
2025
Q1 		$2.5M Buy
439,259
+264,921
+152% +$2.7M 0.02% 1293
2024
Q4 		$1.71M Sell
174,338
-104,343
-37% -$894K 0.01% 1465
2024
Q3 		$2.27M Buy
+278,681
New +$2.79M 0.01% 1353
2024
Q1 		– Sell
-481
Closed -$32.5K – 3850
2023
Q4 		$32.5K Buy
+481
New +$29.5K ﹤0.01% 3312
2023
Q3 		– Sell
-1,025
Closed -$76.3K – 3464
2023
Q2 		$76.3K Sell
1,025
-14,074
-93% -$833K ﹤0.01% 3046
2023
Q1 		$803K Buy
15,099
+7,363
+95% +$467K ﹤0.01% 2352
2022
Q4 		$523K Sell
7,736
-830
-10% -$76.3K ﹤0.01% 2982
2022
Q3 		$1.07M Buy
8,566
+7,471
+682% +$890K 0.01% 2568
2022
Q2 		$104K Buy
+1,095
New +$134K ﹤0.01% 3967
2022
Q1 		– Sell
-28,921
Closed -$9.61M – 3605
2021
Q4 		$9.61M Buy
28,921
+21,956
+315% +$10.4M 0.09% 265
2021
Q3 		$3.23M Buy
+6,965
New +$3.39M 0.04% 706

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's DNA Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 25,743 shares — an estimated $290K sold.

Cubist Systematic Strategies first reported a position in DNA in Q3 2021 and held it in 12 quarters. The position peaked at $9.61M in Q4 2021. 173 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 25,743 Ginkgo Bioworks shares in Q3 2025, an estimated $290K.
  • Cubist Systematic Strategies first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 12 quarters.
  • Cubist Systematic Strategies's Ginkgo Bioworks position peaked at $9.61M in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.